← Leaderboards
Arlene Ramsingh
Wadsworth Center
$1,847,203
Attributed
$1,847,203
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $312.6K · FY2006–10$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,847,203 · 2
By mechanism
R01$1,432,898 · 1
R21$414,305 · 1
Top collaborators
No co-investigators on record.
Most similar at Wadsworth Center
Same institution · by research overlap
- Gary M. Winslow$6,090,601
- Hongmin Li$16,065,705
- William T Lee$2,437,346
Others in their field
Top investigators on “Vector Vaccine”
- Lawrence Corey · Fred Hutchinson Cancer Center$446,547,761
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$239,426,049
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$142,420,923
- Peter B. Gilbert · Fred Hutchinson Cancer Center$124,587,333
- Louis J. Picker · Oregon Health And Science University$70,366,260
- David Heimbrook · Leidos Biomedical Research, Inc.$68,561,099
Research focus
Vector VaccineFutureCellsEvaluationAids VaccinesFitnessAffectDesign And ConstructionEscape MutantEpitopesCategoriesCd4 Positive T LymphocytesBaseAdjuvantEnzyme-Linked Immunosorbent AssayAntibodiesB-LymphocytesCostAntibody FormationCoxsackie VirusesCapsid ProteinsEnzyme Linked Immunospot AssayDesignFunding
Grant awards (8)
HIV vaccine development using recombinant coxsackieviruses$261,599
R01 · FY2010 · AI · contact PI
HIV vaccine development using recombinant coxsackieviruses$260,368
R01 · FY2009 · AI · contact PI
HIV vaccine development using recombinant coxsackieviruses$52,190
R01 · FY2009 · AI · contact PI
HIV vaccine development using recombinant coxsackieviruses$286,186
R01 · FY2008 · AI · contact PI
HIV vaccine development using recombinant coxsackieviruses$286,159
R01 · FY2007 · AI · contact PI
HIV vaccine development using recombinant coxsackieviruses$286,396
R01 · FY2006 · AI · contact PI
T cell immunity to HIV using recombinant enteroviruses$209,102
R21 · FY2003 · AI
T cell immunity to HIV using recombinant enteroviruses$205,203
R21 · FY2002 · AI